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Abstract
Background—To describe recent trends in the receipt of sexually transmitted disease (STD) 
services among women (age, 15–44 years) from 2002 to 2006–2010 using the National Survey of 
Family Growth.
Methods—We analyzed trends in demographics, health insurance, and visit-related variables of 
women reporting receipt of STD services (counseling, testing, or treatment) in the past 12 months. 
We also analyzed trends in the source of STD services and the payment method used.
Results—Receipt of STD services reported by women in the past 12 months increased from 
2002 (12.6%) to 2006–2010 (16.0%; P < 0.001). Receipt of services did not increase among 
adolescents (P = 0.592). Among women receiving STD services from a private doctor/HMO, the 
percentage with private insurance decreased over time (74.6%–66.8%), whereas the percentage 
with Medicaid increased (12.8%–19.7%; P = 0.020). For women receiving STD services at a 
public clinic or nonprimary care facility, there were no statistically significant differences by 
demographics, except that fewer adolescents but more young adults reported using a public clinic 
over time (P = 0.038). Among women who reported using Medicaid as payment, receipt of STD 
services at a public clinic significantly decreased (36.8%–25.4%; P = 0.019). For women who paid 
for STD services with private insurance, the only significant difference was an increase in having a 
copay over time (61.3%–70.1%; P = 0.012).
Conclusions—Despite a significant increase in receipt of STD services over time, many women 
at risk for STDs did not receive services including adolescents. In addition, we identified 
important shifts in payment methods during this time frame.
Sexually transmitted diseases (STDs) continue to be a public health problem and are the 
most commonly reported infectious diseases in the United States.1,2 Some curable bacterial 
STDs are associated with sequelae in women, including chronic pelvic pain, pelvic 
inflammatory disease, infertility, and ectopic pregnancy; however, many infections are 
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asymptomatic.1–3 Chlamydia infections are the most commonly reported notifiable disease 
in the United States, with 610.6 cases per 100,000 women reported for 2010.3 Gonorrhea 
cases, the second most commonly reported disease in the United States, have recently 
increased.4 To reduce the negative health impacts of STDs and identify asymptomatic 
infections, it is important that women receive timely STD services including screening, 
treatment, and counseling.2,3
One example of STD services is screening for chlamydia, recommended routinely by the US 
Preventive Services Task Force for sexually active young women and other women at high 
risk for infection, although few studies have focused on recent trends of these services at the 
national level.5 The Healthcare Effectiveness Data and Information Set measure for 
chlamydia screening examined trends in the United States and found that screening 
increased from 29.8% in 2002 to 41.6% in 2007 among sexually active young women (age, 
16–25 years) enrolled in private health insurance and Medicaid.1 Although the trends 
increased, chlamydia screening in the United States remains at suboptimal levels, even 
among insured women. Similarly, chlamydia testing rates increased significantly from 220 
tests per 1000 person-years in 1997 to 270 tests per 1000 person-years in 2007 among 
women (age, 15–44 years) enrolled in a private health plan.6 However, data in both studies 
are limited to medical claims and exclude uninsured women.
One national study that included uninsured women found a statistically significant increase 
in use of STD services among women from 1995 (7.6%) to 2002 (12.6%),7 but recent trends 
are unknown. Given the potential sequelae of STDs in women and the changing health care 
system in the United States, it is important to monitor trends in the receipt of STD services 
including patterns of use and payment for services. Thus, the purpose of this study is to 
examine recent trends in the receipt of STD services among reproductive-aged women using 
a national survey from 2002 to 2006–2010.
MATERIALS AND METHODS
The National Survey of Family Growth (NSFG) is a nationally representative, cross-
sectional, in-person, household survey of noninstitutionalized men and women aged 15 to 44 
years in the United States.8–10 We analyzed data from the 2002 and 2006–2010 NSFG. In 
2006 to 2010, the NSFG changed to continuous administration where interviews were 
conducted from June 2006 to June 2010.8 The 2006 to 2010 continuous interviewing process 
contained the same primary sampling units as the 2002 survey.8
Given STD sequelae, analyses were restricted to women only. In the 2002 NSFG, 7643 
women were interviewed, and in 2006 to 2010, 12,279 women were interviewed.9,10 In 
2002, the NSFG response rate for women was 80%, and in 2006 to 2010, the response rate 
was 78%.9,10 The NSFG was approved by the Centers for Disease Control and Prevention 
National Center for Health Statistics Ethics Review Board. Participants provided informed 
consent; subsequent to parental consent, adolescent respondents provided assent.
We analyzed the demographic characteristics, health insurance, and visit-related variables of 
women reporting receipt of STD services in the 12 months before interview. Receipt of STD 
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services was ascertained by asking women if they had received counseling for or been tested 
or treated for an STD in the past 12 months, with a dichotomized response (yes or no). The 
demographic characteristics included in analyses were age (15–19, 20–24, or 25–44 years), 
race/ethnicity (Hispanic, non-Hispanic white, non-Hispanic black, or non-Hispanic other), 
and poverty-income ratio. The poverty-income ratio was calculated from the household 
income as a percentage of the federal poverty level (FPL; recoded as 0–132% or ≥133%).
Two health insurance variables were included in analyses. The first variable, current health 
insurance status, categorized women into 4 insurance groups: (1) private health insurance or 
Medi-Gap (“private”); (2) Medicaid, Children’s Health Insurance Program, or state-
sponsored health plan (“Medicaid”); (3) Medicare, military health care, or other government 
health care (“Medicare”); or (4) currently covered only by a single-service plan, only by the 
Indian Health Service, or currently not covered by health insurance (“no insurance”). 
Respondents chose from health insurance options, which included the name of the Medic-
aid program specific to their state (eg, Medi-Cal in California). The second health insurance 
variable identified if women had a gap in health insurance coverage in the past 12 months 
(yes or no).
Visit-related variables included the self-reported type of clinic where women reported 
receipt of the STD service (recoded as “private doctor/HMO,” “public clinic,” “family 
planning,” or “nonprimary care” location) and payment method for the STD service 
(Medicaid, private insurance, out-of-pocket, or no payment required). The nonprimary care 
location for the type of clinic that a respondent received STD services includes employer or 
company clinic, school or school-based clinic, hospital outpatient clinic, hospital emergency 
department, hospital regular room, urgent care, urgi-care, walk-in facility, or some other 
place. Payment method for the STD service was a “mark all that apply” variable that we 
recoded into a categorical variable with priority given to responses in the following order: 
Medicaid, private insurance, out-of-pocket, or no payment required. Medicaid was 
prioritized because STDs are higher among this population.11 The final visit-related variable 
included in our analyses was whether or not the clinic where the respondent received STD 
services was the regular place for their medical care with 4 response options: (1) yes, regular 
place; (2) yes, regular place but go to more than 1 place regularly; (3) usually go somewhere 
else; or (4) not the usual place for medical care. The place for regular medical care was 
applicable for women who reported receipt of STD services in the following clinics only: 
community health clinic, community clinic, or public health clinic; family planning or 
Planned Parenthood; school or school-based clinic; or hospital outpatient clinic.
We further analyzed the place where women reported receipt of STD services in the past 12 
months by demographic characteristics and health insurance variables. Then, the payment 
methods for STD services were analyzed by demographics and health insurance variables. 
Finally, we analyzed payment methods for STD services by the place where the service was 
received and whether or not the women had a copay.
Analyses were conducted using SAS-callable SUDAAN, release 11.0.0 (Research Institute, 
Research Triangle Park, NC) to account for the complex sample design, multistage sample 
procedures, and sampling weights.12,13 Analyses were weighted to represent US women 
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aged 15 to 44 years.14 Cochran-Mantel-Haenszel and χ2 tests were conducted to compare 
receipt of STD services in the past 12 months over time, from 2002 to 2006–2010.
RESULTS
Receipt of STD services reported by women in the past 12 months increased from 12.6% in 
2002 to 16.0% in 2006 to 2010 (P < 0.001; Table 1). However, receipt of STD services did 
not significantly increase from 2002 to 2006–2010 among certain subgroups of women 
including the following: adolescents aged 15 to 19 years (P = 0.592); women who identified 
as “other” (non-Hispanic) racial/ethnic groups (P = 0.924); women currently enrolled in 
Medicare, military, or other government health insurance plans (P = 0.117); or among 
women who were not currently enrolled in health insurance (P = 0.302). In post hoc analyses 
(data not show in tables), among sexually active (reported sex in the past 12 months) 
respondents only, adolescents who reported receipt of STD services did not significantly 
increase from 2002 to 2006–2010 (27.2%–28.2%; P = 0.701). Among women who reported 
receiving STD services in the past 12 months, visit-related characteristics did not 
significantly increase over time for the place where the STD service was received (P = 
0.202) or for the clinic being the regular place for medical care (P = 0.077), but there were 
significant differences in payment method (P = 0.021) from 2002 to 2006–2010 (Table 1).
Trends in the type of health care provider or clinic where women received STD services 
were examined by demographics (Table 2). Among women receiving STD services from a 
private doctor/HMO, the percentage who had private insurance decreased from 74.6% in 
2002 to 66.8% in 2006 to 2010, whereas the percentage who had Medicaid increased from 
12.8% in 2002 to 19.7% in 2006 to 2010 (P = 0.020). However, among these women, there 
were no significant differences by age, race/ethnicity, poverty-income ratio, or health 
insurance gap in the past 12 months. For women receiving STD services at a public or 
family planning clinic, there were no statistically significant differences by race/ethnicity, 
poverty-income ratio, health insurance status, and health insurance gap in the past 12 
months. However, as compared with 2002, fewer adolescent women (15–19 years) but more 
young adult women (20–24 years) reported using a public clinic (P = 0.038) for STD 
services. Findings for women who received STD services at a family planning clinic were 
similar to those for public clinic. For nonprimary care locations (eg, employer or company 
clinic, school or school-based clinic, hospital outpatient clinic, hospital emergency 
department, hospital regular room, urgent care, urgi-care, walk-in facility, or some other 
place) where women received STD services, there were no significant differences between 
2002 and 2006–2010 for all characteristics measured (age, race/ethnicity, poverty-income 
ratio, health insurance status, and health insurance gap in past 12 months).
Owing to sample sizes for the nonprimary health care setting where women reported 
receiving STD services, we were unable to statistically compare the health insurance status 
among women who received STD services at different clinics during the same time frame. 
However, there seemed to be different patterns in health insurance status among women 
attending public clinics or family planning clinics and those who received STD services 
from private doctors/HMOs (Table 2). In 2006 to 2010, only 27.1% of women attending 
public health clinics and 35.7% attending family planning clinics were currently enrolled in 
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private health insurance as compared with 66.8% of women attending a private doctor/
HMO. Also in 2006 to 2010, approximately half of women who attended public clinics 
(43.4%) and family planning clinics (54.4%) for STD services had a gap in health insurance 
status in the past 12 months compared with only 23.7% who attended a private doctor/HMO.
Finally, trends in reported methods of payment for STD services from 2002 to 2006–2010 
were examined by demographic and visit-related variables (Table 3). Among women who 
reported using Medicaid as the payment method for STD services, there was a slight 
decrease in the percentage who had a household income less than 133% of FPL (73.8% in 
2002 to 65.5% in 2006–2010; P = 0.061). Also among these women, receipt of services at a 
public clinic significantly decreased (36.8% in 2002 to 25.4% in 2006–2010; P = 0.019), 
with smaller increases for receipt of services at private doctors/HMOs, family planning, and 
nonprimary care locations. There were no significant differences for women who paid for 
STD services with Medicaid by the remaining demographics. Conversely, for women who 
paid for STD services with private insurance, the only significant difference across time was 
an increase in having a copay from 2002 (61.3%) to 2006–2010 (70.1%) (P = 0.012). There 
were no other differences across time for women who paid with private insurance. Also, 
there were no significant differences among women who paid out of pocket or who reported 
that no payment was required.
DISCUSSION
We found that the number of reproductive-aged women who reported receiving STD 
services in the past 12 months increased from 2002 to 2006–2010, continuing an earlier 
trend in increased use of STD services observed from 1995 to 2002.7 Increases in receipt of 
STD services were observed for all payer types; however, these increases were not 
statistically significant for Medicare recipients or the uninsured. More than half of uninsured 
Americans have incomes less than 200% of the FPL,15 and low-income patients tend to be 
disproportionately affected by STDs such as chlamydia.11 Therefore, it is important for 
private providers and HMOs to be aware of the needs of this subpopulation, especially in a 
changing health care system.
In addition, there was no increase in receipt of STD services among adolescents (15–19 
years), nor was there a significant increase among sexually active adolescents (reported sex 
in the past 12 months). These findings are important because adolescents have the highest 
burden of STDs.2 Although the Centers for Disease Control and Prevention recommends 
screening sexually active women younger than 26 years for chlamydia on an annual basis, 
screening remains at suboptimal levels.2,16–18 Furthermore, we found a significant decrease 
in adolescents who reported that they received services in public clinics and a non-
significant declining trend for family planning clinics; however, the percentage of 
adolescents who received STD services at private providers, family planning clinics, and 
nonprimary care clinics did not change.
The health care setting where women receive STD services is important, especially public 
and family planning clinics. Among the women reporting STD services in public, family 
planning, school, or hospital outpatient clinics having a usual place for medical care 
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decreased but did not significantly differ from 2002 to 2006–2010. Similar findings are seen 
in the National Health Interview Study, where having a usual place for medical care 
decreased from 2003 to 2010 among Americans of all ages.19 Thus, public clinics may serve 
as a “safety net” for STD services.20 Furthermore, there may be anonymity and 
confidentiality concerns with STD screening,21,22 and at least one study found that women 
seek services from family planning clinics for confidentiality reasons including receiving 
services without using insurance.23
Our findings also highlight the insurance status of reproductive-aged women who received 
STD services at different health care settings. First, there was a significant increase in the 
number of reproductive-aged women with Medicaid who received STD services from 
private providers or HMOs in 2006 to 2010. Furthermore, of women who reported using 
Medicaid to pay for their service, fewer reported receiving services from a public clinic. 
Finally, a substantial proportion of women who received STD services from public or family 
planning clinics did not have health insurance in either time frame.
It is important for public and private providers to be aware of how having insurance 
coverage changes women’s access to, payment of, and health seeking behaviors for STD 
services. As of May 2013, the Congressional Budget Office estimated that in 2014, the first 
year in which many of the Affordable Care Act’s provisions will be inaugurated, the effect 
of the law will reduce the nonelderly uninsured population by 14 million persons.24 The law 
is projected to further reduce the number of persons uninsured in subsequent years; after 5 
years postimplementation in 2019, 30 million nonelderly Americans, including 
undocumented immigrants, will remain uninsured.24 In addition, some states have proposed, 
or have begun, to close their publicly funded clinics that specialize in STD-related services 
because of budgetary shortfalls, eliminating a safety net for STD services.25 We found that 
approximately 1 in 5 women sought STD services in these safety net clinics.
Finally, we found a significant increase in copays for women who paid for their STD service 
using private insurance. In 2006 to 2010, 7 in 10 privately insured women paid a copay for 
their STD service. The Affordable Care Act provision mandating first dollar coverage of 
certain recommended preventive services (not including treatment) may alleviate this burden 
on women, particularly for some STD screening and counseling services.26 By 2012, 41% of 
workers were covered by employer-sponsored health plans that expanded preventive services 
because of the Affordable Care Act.27 However, the requirement applies only to non–
grandfathered private plans, so cost sharing remains for some individuals with private 
insurance.28
There are some limitations to this study. The survey item for receipt of STD services 
included 3 topics (STD counseling, testing, or treatment); therefore, it was not possible to 
examine only women who received an STD test. In addition, the variable was self-reported, 
and it is possible that some women may not always know when they are tested for an STD if 
the visit occurred during other preventive services such as birth control, annual pelvic 
examinations, or Papanicolaou testing. However, there is no evidence that the self-report bias 
has changed over time. Because it is not possible to parse out the specific STD service 
(counseling, testing, or treatment), we are not able to determine which visits were for 
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preventive services rather than for treatment. Finally, given relatively small sample sizes, we 
were not able to look at other clinic types such as school-based clinics and hospital 
emergency departments.
This study presents the most recent, national-level trends for receipt of STD services among 
reproductive-aged women. Although self-reported receipt of STD services in the past 12 
months significantly increased among women of childbearing age from 2002 to 2006–2010, 
less than 1 in 5 women (age, 15–44 years) and less than 1 in 3 young adult women (age, 20–
24 years) received STD services. In addition, less than 1 in 6 adolescents (age, 15–19 years) 
overall and 1 in 4 sexually active adolescents received STD services. Our findings highlight 
important changes in the use and payment of STD services among reproductive-aged women 
and may be useful for health care providers (public and private), health departments, and 
public health programs.
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TABLE 1
Self-Reported Receipt of STD Service in the Past 12 Months Among Women (15–44 Years): Demographic 
and Visit-Related Characteristics, 2002 (n = 7633) and 2006–2010 (n = 12,272)
Year
2002, % (SE) 2006–2010, % (SE) P
Unweighted sample size n = 7633 n = 12,272
Population total estimate 61,500,000 61,700,000
Receipt of STD service in past 12 mo <0.001
 Yes 12.6 (0.5) 16.0 (0.6)
 No 87.4 (0.5) 84.0 (0.6)
Women who reported receipt of STD service in past 12 mo
 Unweighted sample size n = 1092 n = 2230
 Population total estimate 7,700,000 9,800,000
Demographics
 Age, y <0.001
  15–19 15.2 (1.1) 14.3 (1.1) 0.592
  20–24 22.3 (1.4) 30.0 (1.8) <0.001
  25–44 9.7 (0.5) 12.8 (0.6) <0.001
 Race/ethnicity <0.001
  Hispanic 12.5 (1.0) 15.8 (1.0) 0.019
  White (non-Hispanic) 12.0 (0.7) 14.7 (0.8) 0.010
  Black (non-Hispanic) 16.1 (1.1) 23.7 (1.3) <0.001
  Other (non-Hispanic) 11.1 (1.9) 11.3 (1.5) 0.924
 Poverty-income ratio <0.001
  0–132% 15.1 (0.9) 18.6 (0.9) 0.007
  ≥133% 11.6 (0.5) 14.7 (0.7) <0.001
 Health insurance status (current) <0.001
  Private insurance* 11.1 (0.5) 13.4 (0.7) 0.007
  Medicaid, CHIP, state-sponsored health plan 18.6 (1.5) 25.0 (1.6) 0.004
  Medicare, military, other government plan 17.6 (2.4) 23.4 (2.7) 0.117
  No insurance† 13.9 (1.4) 15.7 (1.1) 0.302
 Health insurance gap in past 12 mo <0.001
  Yes 15.6 (1.3) 19.0 (1.1) 0.040
  No 11.7 (0.5) 14.9 (0.7) <0.001
Visit-related characteristics
 Place received STD service 0.202
  Private doctor/HMO 59.3 (1.8) 56.1 (1.9)
  Community health clinic, community clinic, public health clinic 19.5 (1.3) 18.3 (1.4)
  Family planning or Planned Parenthood 9.7 (1.3) 12.1 (1.1)
  Nonprimary care‡ 11.5 (1.1) 13.4 (1.0)
 Payment method n = 1060 n = 2162 0.021
Sex Transm Dis. Author manuscript; available in PMC 2018 February 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Haderxhanaj et al. Page 10
Year
2002, % (SE) 2006–2010, % (SE) P
  Medicaid 18.5 (1.4) 24.9 (1.5)
  Insurance 54.1 (2.1) 49.9 (2.3)
  Out-of-pocket 14.9 (1.7) 14.2 (1.5)
  No payment required 12.5 (1.4) 11.0 (1.2)
 Clinic is a regular place for medical care§ n = 394 n = 910 0.077
  Regular place 54.8 (3.0) 59.6 (3.0)
  Regular place, but go to >1 place regularly 5.5 (1.4) 4.3 (0.9)
  Usually go somewhere else 33.9 (3.3) 25.9 (2.3)
  No usual place 5.8 (1.4) 10.2 (1.8)
Cochran–Mantel–Haenszel tests were used to compare trends in receipt of STD services for each subgroup.
*
Private insurance category includes participants enrolled in Medi-Gap.
†No insurance category includes participants with single-service plans or Indian Health Service.
‡Nonprimary care category includes employer or company clinic, school or school-based clinic, hospital outpatient clinic, hospital emergency 
department, hospital regular room, urgent care, urgi-care, or walk-in facility, or some other place.
§
Item was applicable to those who had an STD service in the following clinics only: community health clinic, community clinic, or public health 
clinic; family planning or Planned Parenthood; school or school-based clinic; and hospital outpatient clinic.
STD service indicates counseling, testing, and/or treatment of STD.
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